Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003

被引:21
作者
Vellozzi, C
Lane, JM
Averhoff, F
Maurer, T
Norton, S
Damon, I
Casey, C
机构
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Poxvirus Program, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[3] Logist Hlth Inc, La Crosse, WI USA
[4] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[5] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[6] Ctr Dis Control & Prevent, Smallpox Eradicat Program, Atlanta, GA 30333 USA
关键词
D O I
10.1086/432584
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Generalized vaccinia (GV), progressive vaccinia (PV), and eczema vaccinatum (EV) are adverse reactions following smallpox vaccination. We investigated all reports suggestive of GV, PV, or EV among United States civilian smallpox vaccinees during 2003 and applied standard case definitions. We identified 29 reports of possible GV among 38,440 vaccinees; 2 (7%) of the reports met the case definition. One case of GV was confirmed by identifying vaccinia from a lesion distant from the vaccine site using polymerase chain reaction. The other case was classified as probable GV, because confirmatory testing was not done. We identified 3 potential EV cases and 7 potential PV cases, none of which met the standard case definition. GV, PV, and EV were rare or absent following smallpox vaccination after careful screening of potential vaccinees. GV may be difficult to distinguish from other rashes, and confirmatory testing is recommended. Careful prevaccination screening probably contributed to the low incidence of these adverse reactions following smallpox vaccination.
引用
收藏
页码:689 / 697
页数:9
相关论文
共 29 条
[1]   OBSERVATIONS ON VACCINIAL ERUPTIONS AND DIFFERENTIAL DIAGNOSIS OF GENERALIZED VACCINIA [J].
ANGULO, JJ ;
BASSOI, ON ;
BRITTO, TD ;
CUBASDOS.C ;
SALLESGOMES, LF .
POSTGRADUATE MEDICAL JOURNAL, 1962, 38 (437) :145-&
[2]   Risks of serious complications and death from smallpox vaccination:: A systematic review of the United States experience, 1963-1968 -: art. no. 26 [J].
Aragón, TJ ;
Ulrich, S ;
Fernyak, S ;
Rutherford, GW .
BMC PUBLIC HEALTH, 2003, 3 (1) :1-12
[3]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P893
[4]   THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS) [J].
CHEN, RT ;
RASTOGI, SC ;
MULLEN, JR ;
HAYES, SW ;
COCHI, SL ;
DONLON, JA ;
WASSILAK, SG .
VACCINE, 1994, 12 (06) :542-550
[5]  
COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906
[6]  
DEWAR W A, 1954, Glasgow Med J, V35, P141
[7]   Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox [J].
Earl, PL ;
Americo, JL ;
Wyatt, LS ;
Eller, LA ;
Whitbeck, JC ;
Cohen, GH ;
Eisenberg, RJ ;
Hartmann, CJ ;
Jackson, DL ;
Kulesh, DA ;
Martinez, MJ ;
Miller, DM ;
Mucker, EM ;
Shamblin, JD ;
Zwiers, SH ;
Huggins, JW ;
Jahrling, PB ;
Moss, B .
NATURE, 2004, 428 (6979) :182-185
[8]   Smallpox vaccination: Risk considerations for patients with atopic dermatitis [J].
Engler, RJM ;
Kenner, J ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) :357-365
[9]  
ERIKSSON GUNNEL, 1966, ACTA MED SCAND, VSuppl. 464, P147
[10]   Smallpox vaccination: A review, part II. Adverse events [J].
Fulginiti, VA ;
Papier, A ;
Lane, JM ;
Neff, JM ;
Henderson, DA .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :251-271